A Study of ARRY-371797 in Patients With Active Ankylosing Spondylitis
Status:
Terminated
Trial end date:
2009-09-29
Target enrollment:
Participant gender:
Summary
This is a Phase 2 study, involving a 12-week treatment period, designed to evaluate the
effectiveness of investigational study drug ARRY-371797 (versus placebo) in treating
ankylosing spondylitis, and to further evaluate the drug's safety. Approximately 130 patients
from the US, Canada, Poland and Hungary will be enrolled in this study.